The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (£272m) spanning five years because of Washington's insistence on sensitive biological samples.
This move became public after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "skewed".
A government representative has since clarified that the United States was demanding access to genetic material for scientific study and commercial purposes while was unwilling to share the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to find a agreement suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Context
This development comes after a similar situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
Based on reports, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to share its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our nation would supply the basic resources for medical research with no certainty that the end products would be available to our citizens if a new disease outbreak emerge."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This framework is intended to ensure that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to ongoing discussions with our US partners on how subsequent collaboration could be structured in a way that honours the sovereignty and interests of each country."
Medical Community Reaction
Medical experts stated it acknowledged the government's concerns, but suggested that negotiations must proceed since a large portion of the nation's Aids initiatives were funded by international support.
"Where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it said.
The halted deal highlights the continuing tensions between accepting vital foreign assistance and protecting a country's data in an ever more data-driven world.